---
title: "Aptose Shareholders Approve Hanmi Acquisition and Re-Domiciling"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/281295716.md"
description: "Aptose Shareholders Approve Hanmi Acquisition and Re-Domiciling"
datetime: "2026-04-01T03:33:30.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/281295716.md)
  - [en](https://longbridge.com/en/news/281295716.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/281295716.md)
generator: "portal-rs"
---

# Aptose Shareholders Approve Hanmi Acquisition and Re-Domiciling

Aptose Shareholders Approve Hanmi Acquisition and Re-Domiciling

### Related Stocks

- [VHT.US](https://longbridge.com/en/quote/VHT.US.md)
- [LABU.US](https://longbridge.com/en/quote/LABU.US.md)
- [ARKG.US](https://longbridge.com/en/quote/ARKG.US.md)
- [BIB.US](https://longbridge.com/en/quote/BIB.US.md)
- [APTOF.US](https://longbridge.com/en/quote/APTOF.US.md)
- [IBB.US](https://longbridge.com/en/quote/IBB.US.md)
- [BBH.US](https://longbridge.com/en/quote/BBH.US.md)
- [XLV.US](https://longbridge.com/en/quote/XLV.US.md)
- [SBIO.US](https://longbridge.com/en/quote/SBIO.US.md)
- [PBE.US](https://longbridge.com/en/quote/PBE.US.md)
- [APTO.US](https://longbridge.com/en/quote/APTO.US.md)
- [FBT.US](https://longbridge.com/en/quote/FBT.US.md)
- [XBI.US](https://longbridge.com/en/quote/XBI.US.md)
- [IHE.US](https://longbridge.com/en/quote/IHE.US.md)

## Related News & Research

- [Sacituzumab Govitecan Plus Pembrolizumab Does Not Meet Primary Endpoints in First-Line PD-L1-High Metastatic NSCLC](https://longbridge.com/en/news/298830378.md)
- [FDA grants priority review to Genentech’s Enspryng for MOGAD](https://longbridge.com/en/news/298539804.md)
- [09:28 ETNew LabCentral Program "The Loop" Offers International Biotech Start-Ups and Partner Organizations Curated Learnings Directly from U.S. Market](https://longbridge.com/en/news/298328140.md)
- [SBIO: U.S. Programmatic and EMEA drove 49% of Q2 sales, with margins rising to 61% and profitability expected in H2 2026](https://longbridge.com/en/news/296517769.md)
- [“We’re not doing 30 bets a year”: Vijay Pande on betting small after running $4 billion at a16z](https://longbridge.com/en/news/297407072.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**